ଫ୍ଲାଭୋକ୍ସେଟ

ଫ୍ଲାଭୋକ୍ସେଟ
Clinical data
Pronunciation	flay vox' ate
Trade names	Urispas, others
Synonyms	Flavoxate hydrochloride
AHFS/Drugs.com	monograph
MedlinePlus	a682706
Identifiers
	IUPAC name 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;
ECHA InfoCard	100.035.745
Chemical and physical data
Formula	C24H25NO4
Molar mass	୩୯୧.୪୭ g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCCN1CCCCC1)c4cccc2c4O/C(=C(\C2=O)C)c3ccccc3;
	InChI InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3 ; Key:SPIUTQOUKAMGCX-UHFFFAOYSA-N ;
(verify)

ଫ୍ଲାଭୋକ୍ସେଟ (ଇଂରାଜୀ ଭାଷାରେ Flavoxate), ଅନ୍ୟମାନଙ୍କ ମଧ୍ୟରେ ୟୁରିସ୍ପାସ (Urispas) ହେଉଛି ଏକ ଔଷଧ ଯାହା ଅତିସକ୍ରିୟ ମୂତ୍ରାଶୟର ଚିକିତ୍ସା ପାଇଁ ବ୍ୟବହୃତ ହୁଏ ।^[୨] ଏହା ମୂତ୍ରାଙ୍ଗ ସଂକ୍ରମଣର ଲକ୍ଷଣ ପାଇଁ ମଧ୍ୟ ବ୍ୟବହୃତ ହୋଇପାରେ ।^[୩] ଏହା ପାଟିରେ ଦିଆଯାଏ ।^[୨]

ସାଧାରଣ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଶୁଖିଲା ପାଟି, ଝାଳ ବୋହିବା ହ୍ରାସ, ମୁଣ୍ଡବିନ୍ଧା, ଅସ୍ପଷ୍ଟ ଦୃଷ୍ଟିଶକ୍ତି, କୋଷ୍ଠକାଠିନ୍ୟ, ମୂତ୍ର ଧାରଣ, ଯୌନ ଅସୁବିଧା, ଛାତି ଧଡ଼ ଧଡ଼ ହେବା ଏବଂ ଉତେଜନା ହୋଇପାରେ ।^[୧] ଗର୍ଭାବସ୍ଥାରେ ବ୍ୟବ‌ହାର କଲେ କ୍ଷତିର କୌଣସି ପ୍ରମାଣ ନଥିବାବେଳେ, ଏପରି ବ୍ୟବହାର ଭଲ ଭାବରେ ଅଧ୍ୟୟନ କରାଯାଇ ନାହିଁ | ^[୪] ଏହା ଏକ ଆଣ୍ଟିସ୍ପାଜମୋଡିକ ଏବଂ ଆଣ୍ଟିକୋଲିନରଜିକ୍ ଯାହା ମୂତ୍ରାଶୟର କ୍ଷମତା ବୃଦ୍ଧି କରାଇଥାଏ ଏବଂ ମୂତ୍ର ଆବୃତ୍ତି ହ୍ରାସ କରିଥାଏ ।^[୨] ^[୧]

୧୯୭୦ରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଚିକିତ୍ସା କ୍ଷେତ୍ରରେ ବ୍ୟବହାର ପାଇଁ ଫ୍ଲାଭୋକ୍ସେଟ ଅନୁମୋଦିତ ହୋଇଥିଲା ।^[୨] ଏହା ଏକ ସାଧାରଣ ଔଷଧ ଭାବରେ ଉପଲବ୍ଧ । ^[୧] ଯୁକ୍ତରାଜ୍ୟରେ ୨୦୦ ମିଗ୍ରା ବିଶିଷ୍ଟ ୯୦ଟି ବଟିକାର ମୂଲ୍ୟ ୨୦୨୧ ସୁଦ୍ଧା ୧୨ ପାଉଣ୍ଡ ଥିଲା ।^[୫] ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଏହି ରାଶିର ମୂଲ୍ୟ ପ୍ରାୟ ୪୮ ଡଲାର ଅଟେ ।^[୬]

ଆଧାର

↑ ^୧.୦ ^୧.୧ ^୧.୨ ^୧.୩ "Flavoxate". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. 2012. Archived from the original on 6 May 2021. Retrieved 11 December 2021.
↑ ^୨.୦ ^୨.୧ ^୨.୨ ^୨.୩ "FlavoxATE Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 19 January 2021. Retrieved 11 December 2021.
↑ "DailyMed - FLAVOXATE HYDROCHLORIDE tablet". dailymed.nlm.nih.gov. Archived from the original on 14 July 2017. Retrieved 11 December 2021.
↑ "Flavoxate (Urispas) Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 28 October 2020. Retrieved 11 December 2021.
↑ BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 822. ISBN 978-0857114105.
↑ "Flavoxate Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 11 December 2021.

[Liv2021-1] ୧.୦ ^୧.୧ ^୧.୨ ^୧.୩ "Flavoxate". LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases. 2012. Archived from the original on 6 May 2021. Retrieved 11 December 2021.

[AHFS2021-2] ୨.୦ ^୨.୧ ^୨.୨ ^୨.୩ "FlavoxATE Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 19 January 2021. Retrieved 11 December 2021.

[PI2021-3] "DailyMed - FLAVOXATE HYDROCHLORIDE tablet". dailymed.nlm.nih.gov. Archived from the original on 14 July 2017. Retrieved 11 December 2021.

[4] "Flavoxate (Urispas) Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 28 October 2020. Retrieved 11 December 2021.

[BNF81-5] BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 822. ISBN 978-0857114105.

[6] "Flavoxate Prices, Coupons & Savings Tips - GoodRx". GoodRx. Retrieved 11 December 2021.

[୨]

[୩]

[୧]

[୪]

[୫]

[୬]

Clinical data

Pronunciation	flay vox' ate^[୧]
Trade names	Urispas, others
Synonyms	Flavoxate hydrochloride
AHFS/Drugs.com	monograph
MedlinePlus	a682706
Identifiers
IUPAC name 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate
ECHA InfoCard	100.035.745
Chemical and physical data
Formula	C₂₄H₂₅NO₄
Molar mass	୩୯୧.୪୭ g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES O=C(OCCN1CCCCC1)c4cccc2c4O/C(=C(\C2=O)C)c3ccccc3
InChI InChI=1S/C24H25NO4/c1-17-21(26)19-11-8-12-20(23(19)29-22(17)18-9-4-2-5-10-18)24(27)28-16-15-25-13-6-3-7-14-25/h2,4-5,8-12H,3,6-7,13-16H2,1H3^Y Key:SPIUTQOUKAMGCX-UHFFFAOYSA-N^Y
(verify)